CVSS 3.1
6.5 mediumCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:NMedium (6.5). EPSS 0.4% estimated probability of exploitation activity in the next 30 days. Fixed in @vitest/ui 5.0.5.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N@vitest/ui (npm): fixed in 5.0.5@vitest/browser (npm): fixed in 5.0.5vite-plus (npm): fixed in 1.3.0Explain CVE-2026-112948 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2026-112948?via=ask-ai-copy and https://cve.bz/cve/CVE-2026-112948?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2026-112948 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.
From the CNA's record in the CVE List.
| Product | Affected |
|---|---|
| vitest-dev vitest | >= 5.0.0-beta.6, < 5.0.5 |
| @vitest browser | >= 5.0.0-beta.6, < 5.0.5 |
| @vitest ui | >= 5.0.0-beta.6, < 5.0.5 |
| vitejs vite-plus | >= 1.0.0-rc.0, < 1.3.0 |
| Advisory | Ecosystem | Package | Affected | Fixed in |
|---|---|---|---|---|
| GHSA-p458-7748-mcp3 | npm | @vitest/ui | >=5.0.0-beta.6 <5.0.5 | 5.0.5 |
| GHSA-p458-7748-mcp3 | npm | @vitest/browser | >=5.0.0-beta.6 <5.0.5 | 5.0.5 |
| GHSA-p458-7748-mcp3 | npm | vite-plus | >=1.0.0-rc.0 <1.3.0 | 1.3.0 |
Red Hat rates this Moderate.
This vulnerability is rated as having Moderate impact for Red Hat products because it exclusively affects interactive development server modes, such as the UI or Browser Mode, rather than standard non-interactive test runs or production environments. Exploitation requires either direct network reachability to the developer's local testing server or a developer visiting an untrusted webpage while running multi-project browser tests. Standard automated test execution and compiled runtime artifacts do not expose these HTTP services, limiting the attack surface.
| Product | Package | State | Advisory |
|---|---|---|---|
| Red Hat AMQ Broker 7 | amq-broker-bin.zip | Fix deferred | |
| Red Hat AMQ Broker 7 | amq-broker-maven-repository.zip | Fix deferred | |
| Red Hat Ansible Automation Platform 2 | ansible-automation-platform-26/gateway-rhel9 | Fix deferred | |
| Red Hat Ansible Automation Platform 2 | ansible-automation-platform-27/gateway-rhel9 | Fix deferred | |
| Red Hat Ansible Automation Platform 2 | automation-gateway | Out of support scope | |
| Red Hat Ansible Automation Platform 2 | automation-platform-ui | Fix deferred | |
| Red Hat Build of Keycloak | keycloak-operator.redhat-00001.zip | Fix deferred | |
| Red Hat Build of Keycloak | keycloak-operator.redhat-00003.zip | Fix deferred | |
| Red Hat Build of Keycloak | rhbk-quarkus-dist.zip | Fix deferred | |
| Red Hat Build of Podman Desktop | rh-podman-desktop | Fix deferred | |
| Red Hat Hardened Images | prometheus3.13 | Not affected | |
| Red Hat JBoss Enterprise Application Platform 8 | jboss-eap.1-runtime-maven-repository.zip | Fix deferred | |
| Red Hat JBoss Enterprise Application Platform 8 | jboss-eap-runtime-maven-repository.zip | Fix deferred | |
| Red Hat JBoss Enterprise Application Platform Expansion Pack | jboss-eap.1-runtime-maven-repository.zip | Fix deferred | |
| Red Hat JBoss Enterprise Application Platform Expansion Pack | jboss-eap-runtime-maven-repository.zip | Fix deferred | |
| Red Hat Trusted Artifact Signer | rhtas/rhtas-console-ui-rhel9 | Fix deferred |
Contains Red Hat Security Data © Red Hat, Inc., licensed under CC BY 4.0. Source: https://access.redhat.com/security/data. Modified: reformatted. Red Hat's page for CVE-2026-112948.
The attack patterns MITRE's CAPEC relates to this record's weaknesses, as MITRE names them. Credits. More on the page of CWE-200 (59).